Vladimir Moiseyenko Selected Research

Vladimir Moiseyenko Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 06/2002
9	Breast Neoplasms (Breast Cancer) 05/2023 - 06/2002
4	Neutropenia 01/2017 - 03/2010
3	Disease Progression 01/2023 - 06/2002
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 06/2015
3	Febrile Neutropenia 01/2017 - 06/2015
3	Colorectal Neoplasms (Colorectal Cancer) 10/2012 - 01/2007
2	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 07/2007
2	Ascites 01/2024 - 07/2007
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2007
1	Carcinoma (Carcinomatosis) 01/2024
1	Heart Diseases (Heart Disease) 08/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Microsatellite Instability 09/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Anorexia 06/2015
1	Weight Loss (Weight Reduction) 06/2015
1	Vomiting 07/2012
1	Nausea 07/2012
1	Adenocarcinoma 03/2010
1	Hypokalemia 03/2010
1	Stomatitis 03/2010
1	Kidney Neoplasms (Kidney Cancer) 01/2007
1	Hand-Foot Syndrome 06/2002
1	Fever (Fevers) 06/2002
1	Sepsis (Septicemia) 06/2002
1	Arthralgia (Joint Pain) 06/2002
1	Myalgia 06/2002

Drug/Important Bio-Agent (IBA)

4	Trastuzumab (Herceptin)FDA Link 05/2023 - 01/2017
3	CT-P6IBA 05/2023 - 01/2017
3	Biosimilar PharmaceuticalsIBA 08/2021 - 01/2017
3	AnthracyclinesIBA 01/2017 - 06/2002
3	Docetaxel (Taxotere)FDA Link 01/2016 - 06/2002
3	Fluorouracil (Carac)FDA LinkGeneric 06/2015 - 03/2010
2	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 01/2024 - 01/2022
2	Epidermal Growth Factor (EGF)IBA 05/2023 - 08/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2021 - 09/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 10/2012
2	balugrastimIBA 01/2016 - 06/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016 - 06/2015
2	pegfilgrastim (Neulasta)FDA Link 01/2016 - 06/2015
2	Cisplatin (Platino)FDA LinkGeneric 06/2015 - 03/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2012 - 07/2012
2	Capecitabine (Xeloda)FDA Link 10/2004 - 06/2002
1	SolutionsIBA 01/2024
1	Sodium Chloride FDA LinkGeneric 01/2024
1	alofanibIBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Protons (Proton)IBA 01/2022
1	BuffersIBA 01/2022
1	AntibodiesIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	AcidsIBA 01/2022
1	Lactate Dehydrogenase 5IBA 01/2022
1	Proton-Translocating ATPases (ATPase, H+)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	NivolumabIBA 09/2020
1	LigandsIBA 01/2020
1	tremelimumabIBA 01/2020
1	durvalumabIBA 01/2020
1	CTLA-4 AntigenIBA 01/2020
1	Drug CombinationsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 03/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Human Serum Albumin FDA LinkGeneric 06/2015
1	Recombinant ProteinsIBA 06/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2012
1	Bevacizumab (Avastin)FDA Link 10/2012
1	afliberceptIBA 10/2012
1	Leucovorin (Folinic Acid)FDA Link 10/2012
1	Monoclonal AntibodiesIBA 10/2012
1	EmeticsIBA 07/2012
1	Ondansetron (Zofran)FDA LinkGeneric 07/2012
1	casopitantIBA 07/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2012
1	Epithelial Cell Adhesion MoleculeIBA 07/2007
1	catumaxomabIBA 07/2007
1	VaccinesIBA 01/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2007
1	thiamine triphosphorate (TTP)IBA 06/2002

Therapy/Procedure

9	Therapeutics 01/2024 - 06/2002
8	Drug Therapy (Chemotherapy) 01/2024 - 07/2012
5	Neoadjuvant Therapy 05/2023 - 01/2017
2	Immunotherapy 07/2007 - 01/2007
1	Precision Medicine 03/2016